Eun Jin Ju

707 total citations
23 papers, 589 citations indexed

About

Eun Jin Ju is a scholar working on Oncology, Molecular Biology and Biomaterials. According to data from OpenAlex, Eun Jin Ju has authored 23 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Biomaterials. Recurrent topics in Eun Jin Ju's work include Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (7 papers) and Cancer Research and Treatments (6 papers). Eun Jin Ju is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (7 papers) and Cancer Research and Treatments (6 papers). Eun Jin Ju collaborates with scholars based in South Korea, Japan and Belarus. Eun Jin Ju's co-authors include Eun Kyung Choi, Seong‐Yun Jeong, Si Yeol Song, Jung Shin Lee, Jinhyang Choi, Jaesook Park, Jin Seong Lee, Seok Soon Park, Joohee Jung and Hyeyeong Kim and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and Advanced Science.

In The Last Decade

Eun Jin Ju

23 papers receiving 576 citations

Peers

Eun Jin Ju
Yue Geng United States
Jinhyang Choi South Korea
Surya Murty United States
Parisa Yousefpour United States
Erica N. Bozeman United States
Yue Geng United States
Eun Jin Ju
Citations per year, relative to Eun Jin Ju Eun Jin Ju (= 1×) peers Yue Geng

Countries citing papers authored by Eun Jin Ju

Since Specialization
Citations

This map shows the geographic impact of Eun Jin Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eun Jin Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eun Jin Ju more than expected).

Fields of papers citing papers by Eun Jin Ju

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eun Jin Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eun Jin Ju. The network helps show where Eun Jin Ju may publish in the future.

Co-authorship network of co-authors of Eun Jin Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Eun Jin Ju. A scholar is included among the top collaborators of Eun Jin Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eun Jin Ju. Eun Jin Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ju, Eun Jin, Jin Hyoung Park, Eun Jung Ko, et al.. (2023). ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors. Cancer Cell International. 23(1). 172–172. 12 indexed citations
2.
Lee, Jae Hee, Jin Hyoung Park, Seok Soon Park, et al.. (2023). NCK-associated protein 1 regulates metastasis and is a novel prognostic marker for colorectal cancer. Cell Death Discovery. 9(1). 7–7. 13 indexed citations
3.
Park, Seok Soon, Eun Jin Ju, Jin Hyoung Park, et al.. (2023). Targeting phosphomevalonate kinase enhances radiosensitivity via ubiquitination of the replication protein A1 in lung cancer cells. Cancer Science. 114(9). 3583–3594. 4 indexed citations
4.
Park, Yun‐Hee, Seok Soon Park, Eun Jin Ju, et al.. (2021). An Elaborate New Linker System Significantly Enhances the Efficacy of an HER2‐Antibody‐Drug Conjugate against Refractory HER2‐Positive Cancers. Advanced Science. 8(23). e2102414–e2102414. 29 indexed citations
5.
Lee, Kyoung Jin, Eun Jung Ko, Yun‐Yong Park, et al.. (2020). A novel nanoparticle-based theranostic agent targeting LRP-1 enhances the efficacy of neoadjuvant radiotherapy in colorectal cancer. Biomaterials. 255. 120151–120151. 40 indexed citations
6.
Park, Jin, Seok Soon Park, Kyoung Jin Lee, et al.. (2018). Docetaxel-polymeric nanoparticle enhances radiotherapeutic efficacy in human pancreatic cancer. Translational Cancer Research. 7(1). 60–67. 2 indexed citations
7.
Park, Seok Soon, Eun Jin Ju, Jin Hyoung Park, et al.. (2018). Establishment of a Patient-derived Xenograft for Development of Personalized HER2-targeting Therapy in Gastric Cancer. Anticancer Research. 38(1). 287–293. 11 indexed citations
8.
Lee, Kyoung Jin, Jae Hee Lee, Eun Jin Ju, et al.. (2017). A strategy for actualization of active targeting nanomedicine practically functioning in a living body. Biomaterials. 141. 136–148. 9 indexed citations
9.
Park, Seok Soon, Kyoung Jin Lee, Eun Jin Ju, et al.. (2017). Preclinical evaluation of cisplatin-incorporated bio-nanocapsules as chemo-radiotherapy for human hepatocellular carcinoma. Oncology Reports. 38(4). 2259–2266. 6 indexed citations
10.
Park, Seok Soon, Eun Jin Ju, Intae Park, et al.. (2016). Ibulocydine sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis via calpain-mediated Bax cleavage. The International Journal of Biochemistry & Cell Biology. 83. 47–55. 16 indexed citations
11.
Lee, Kyoung Jin, Jae Hee Lee, Eun Jin Ju, et al.. (2016). Application of peptide displaying phage as a novel diagnostic probe for human lung adenocarcinoma. Amino Acids. 48(4). 1079–1086. 27 indexed citations
12.
Choi, Eun Kyung, Jinhyang Choi, Eunkyong Ko, et al.. (2015). Nanoparticulated docetaxel exerts enhanced anticancer efficacy and overcomes existing limitations of traditional drugs. International Journal of Nanomedicine. 10. 6121–6121. 14 indexed citations
13.
Park, Jaesook, Jin Hyoung Park, Eun Jin Ju, et al.. (2015). Multifunctional hollow gold nanoparticles designed for triple combination therapy and CT imaging. Journal of Controlled Release. 207. 77–85. 83 indexed citations
14.
Jung, Joohee, Seong‐Yun Jeong, Seok Soon Park, et al.. (2014). A cisplatin-incorporated liposome that targets the epidermal growth factor receptor enhances radiotherapeutic efficacy without nephrotoxicity. International Journal of Oncology. 46(3). 1268–1274. 13 indexed citations
15.
Park, Seok Soon, Eun Jin Ju, Jinhyang Choi, et al.. (2014). Ibulocydine sensitizes human cancers to radiotherapy by induction of mitochondria-mediated apoptosis. Radiotherapy and Oncology. 112(2). 295–301. 11 indexed citations
16.
Lee, Kyoung Jin, Jae Hee Lee, Jinhyang Choi, et al.. (2014). Novel peptides functionally targeting in vivo human lung cancer discovered by in vivo peptide displayed phage screening. Amino Acids. 47(2). 281–289. 20 indexed citations
17.
Jeong, Seong‐Yun, et al.. (2012). Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy. International Journal of Nanomedicine. 7. 2197–2197. 31 indexed citations
18.
Choi, Jinhyang, Hyeyeong Kim, Eun Jin Ju, et al.. (2012). Use of macrophages to deliver therapeutic and imaging contrast agents to tumors. Biomaterials. 33(16). 4195–4203. 190 indexed citations
19.
Kim, Ji Yeun, Dong Hoon Kwak, Eun Jin Ju, et al.. (2004). Effects of Gamisoyosan onin vitro fertilization and ovulation of stressed mice by electric shock. Archives of Pharmacal Research. 27(11). 1168–1176. 8 indexed citations
20.
Kim, Bo Hyun, et al.. (2004). Involvement of nitric oxide duringin vitro fertilization and early embryonic development in mice. Archives of Pharmacal Research. 27(1). 86–93. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026